Literature DB >> 28382264

Use of Cardiac Computed Tomography for Ventricular Volumetry in Late Postoperative Patients with Tetralogy of Fallot.

Ho Jin Kim1, Da Na Mun1, Hyun Woo Goo2, Tae-Jin Yun1.   

Abstract

BACKGROUND: Cardiac computed tomography (CT) has emerged as an alternative to magnetic resonance imaging (MRI) for ventricular volumetry. However, the clinical use of cardiac CT requires external validation.
METHODS: Both cardiac CT and MRI were performed prior to pulmonary valve implantation (PVI) in 11 patients (median age, 19 years) who had undergone total correction of tetralogy of Fallot during infancy. The simplified contouring method (MRI) and semiautomatic 3-dimensional region-growing method (CT) were used to measure ventricular volumes.
RESULTS: All volumetric indices measured by CT and MRI generally correlated well with each other, except for the left ventricular end-systolic volume index (LV-ESVI), which showed the following correlations with the other indices: the right ventricular end-diastolic volume index (RV-EDVI) (r=0.88, p<0.001), the right ventricular end-systolic volume index (RV-ESVI) (r=0.84, p=0.001), the left ventricular end-diastolic volume index (LV-EDVI) (r=0.90, p=0.001), and the LV-ESVI (r=0.55, p=0.079). While the EDVIs measured by CT were significantly larger than those measured by MRI (median RV-EDVI: 197 mL/m2 vs. 175 mL/m2, p=0.008; median LV-EDVI: 94 mL/m2 vs. 92 mL/m2, p=0.026), no significant differences were found for the RV-ESVI or LV-ESVI.
CONCLUSION: The EDVIs measured by cardiac CT were greater than those measured by MRI, whereas the ESVIs measured by CT and MRI were comparable. The volumetric characteristics of these 2 diagnostic modalities should be taken into account when indications for late PVI after tetralogy of Fallot repair are assessed.

Entities:  

Keywords:  Cardiac computed tomography; Cardiac magnetic resonance imaging; Congenital heart disease; Ventricular volumetry

Year:  2017        PMID: 28382264      PMCID: PMC5380198          DOI: 10.5090/kjtcs.2017.50.2.71

Source DB:  PubMed          Journal:  Korean J Thorac Cardiovasc Surg        ISSN: 2233-601X


Introduction

In the preoperative assessment of congenital heart disease, cardiac magnetic resonance imaging (MRI) has been regarded as the gold standard for the measurement of ventricular volume [1,2]. However, long examination times and the potential need for general anesthesia have limited the use of cardiac MRI in pediatric patients [3,4]. Cardiac computed tomography (CT) may be a suitable alternative in this regard, as the study time is relatively shorter and there is no requirement for general anesthesia. Furthermore, cardiac MRI has the disadvantage of low spatial resolution, leading to difficulties in accurately delineating the endocardial border of the intraventricular structures, such as the papillary muscles and trabeculae. This, in turn, may lead to inaccurate volume measurements, as the ventricular volume between these structures may be inadvertently excluded from calculation. Despite the clinical advantages and putatively superior accuracy of cardiac CT over MRI for ventricular volumetry in patients with congenital heart disease, few studies have directly compared the validity of these 2 imaging modalities in this context [5]. Therefore, we sought to quantify and compare the ventricular volumes measured by both cardiac CT and cardiac MRI in patients with surgically corrected tetralogy of Fallot (TOF) pending pulmonary valve implantation (PVI).

Methods

1) Patients

From our institutional database, we identified 11 patients (1 female) who had undergone total correction of TOF during infancy, and in whom both cardiac MRI and CT examinations were undertaken within 12 months prior to PVI. Cardiac CT was subsequently performed in addition to MRI to obtain detailed anatomical information, including coronary artery distribution, right ventricular outflow tract morphology, and branch pulmonary artery configuration. During the interval between CT and MRI examinations, no catheter or surgical interventions were performed, and deterioration of valve function or changes in ventricular function were not observed on echocardiography. Age at TOF repair, PVI, CT, and MRI are detailed in Table 1.
Table 1

Baseline characteristics

VariableMedian (interquartile range)
Age at TOF repair (mo)9.9 (7.2–11.7)
Age at PVI (yr)19.2 (17.1–22.9)
Interval between TOF repair and PVI (yr)18.3 (16.5–20.9)
Age at cardiac MRI (yr)18.2 (16.5–22.1)
Age at cardiac CT (yr)19.2 (17.0–22.7)
Interval between CT and MRI (mo)5.7 (4.3–9.5)

TOF, tetralogy of Fallot; PVI, pulmonary valve implantation; MRI, magnetic resonance imaging; CT, computed tomography.

2) Outcomes of interest and statistical analysis

The primary outcomes of interest were the ventricular end-diastolic volume index (EDVI) and the end-systolic volume index (ESVI), as measured by both cardiac CT and MRI. All variables were presented as medians with the interquartile range (IQR), and the differences between CT and MRI measurements for each index were assessed using the Wilcoxon signed-rank test. Furthermore, linear correlations between cardiac CT and MRI measurements were analyzed using the Spearman correlation coefficient (r). Intraclass correlations were also analyzed to assess the consistency of ventricular volumetry across the 2 imaging modalities. Finally, Bland-Altman analysis was performed for each pair of EDVI and ESVI values to calculate the limits of agreement.

3) Ventricular volumetry on cardiac magnetic resonance imaging and cardiac computed tomography

For the measurement of ventricular volume using cardiac MRI, a simplified contouring method was used to delineate the compacted endocardial border on short-axis slices [6]. The papillary muscles and trabeculae were excluded from mass measurements. Ventricular volumes at both end-diastolic and end-systolic phases were calculated by adding the endocardial areas of each short-axis slice and multiplying this total by the interslice distance. To measure ventricular volume using cardiac CT, dual-source prospective electrocardiogram (ECG)-triggered and respiratory-triggered cardiac CT were performed using a body size-adapted, low-dose protocol. The technical details regarding the targeting of the end-systolic and diastolic phases in prospective ECG-triggered CT scan are described in a previous report [2]. Ventricular volume was quantified using a semiautomatic 3-dimensional (3D) region-growing method on a commercially available workstation (Advantage Windows 4.6; GE Healthcare, Milwaukee, WI, USA). The endocardial border was delineated using a signal intensity-based thresholding method. The threshold was manually adjusted until the appearances matched our visual assessment.

Results

1) Quantification and comparison of volume indices measured by cardiac magnetic resonance imaging and computed tomography

Table 2 summarizes the ventricular volume indices measured by cardiac CT and MRI, specifically the right ventricular end-diastolic volume index (RV-EDVI), the right ventricular end-systolic volume index (RV-ESVI), the left ventricular end-diastolic volume index (LV-EDVI), and the left ventricular end-systolic volume index (LV-ESVI). The RV-EDVI calculated using the Wilcoxon signed rank test showed that cardiac CT and MRI measurements differed significantly for the RV-EDVI (p=0.008) and the LV-EDVI (p=0.026): RV-EDVI on CT, 197 mL/m2 (IQR, 171–190 mL/m2); RV-EDVI on MRI, 175 mL/m2 (IQR, 185–223 mL/m2); LV-EDVI on CT, 94 mL/m2 (IQR, 82–97 mL/m2); LV-EDVI on MRI, 92 mL/m2 (IQR, 88–104 mL/m2). Both measurements were highly correlated for all volumetric indices except for the LV-ESVI (RV-EDVI: r=0.88, p<0.001; RV-ESVI: r=0.84, p=0.001; LV-EDVI: r=0.90, p=0.001; LV-ESVI: r=0.55, p=0.079). However, the measurement technique did not lead to a significant difference for the right ventricular ejection fraction (RVEF) (p=0.075) or the left ventricular ejection fraction (LVEF) (p=0.248). Likewise, the RVEF and LVEF as measured by both modalities were not significantly correlated (RVEF: r=0.35, p=0.298; LVEF: r=0.25, p=0.467) (Fig. 1).
Table 2

Volumetric data measured by cardiac MRI and CT

VariableMedian (interquartile range)Wilcoxon signed-rank testSpearman test



CTMRIp-valueCorrelation coefficient (r)p-value
RV-EDVI (mL/m2)197 (171–190)175 (182–223)0.0080.88<0.001

RV-ESVI (mL/m2)101 (91–106)101 (82–119)0.7220.840.001

LV-EDVI (mL/m2)94 (82–97)92 (88–104)0.0260.900.001

LV-ESVI (mL/m2)41 (37–46)41 (38–44)0.8590.550.079

RVEF (%)48 (42–47)44 (45–52)0.0750.350.298

LVEF (%)58 (51–56)54 (52–61)0.2480.250.467

MRI, magnetic resonance imaging CT, computed tomography; RV, right ventricle EDVI, end-diastolic volume index; ESVI, end-systolic volume index; LV, left ventricle EF, ejection fraction.

Fig. 1

Scatterplots with slopes and Spearman r for (A) RV-EDVI, (B) RV-ESVI, (C) LV-EDVI, (D) LV-ESVI, (E) RVEF, and (F) LVEF. CT, computed tomography; MRI, magnetic resonance imaging; RV, right ventricle; EDVI, end-diastolic volume index; ESVI, end-systolic volume index; LV, left ventricle; EF, ejection fraction.

2) Agreement of ventricular indices measured by cardiac magnetic resonance imaging and computed tomography

Fig. 2 presents Bland-Altman plots assessing the agreement between measurements made using these 2 imaging modalities. The left ventricular volume indices generally showed a better level of agreement than the right-sided volume indices, as indicated by 95% limits of agreement (RV-EDVI, 85.4 mL/m2; RV-ESVI, 65.2 mL/m2; LV-EDVI, 29.1 mL/m2; LV-ESVI, 29.9 mL/m2). However, when the descriptive values from the Bland-Altman analysis were converted to percentages to evaluate the ratio of 95% limits of agreement to the average volumes measured using cardiac MRI and CT for each volumetric index, the values (expressed as mean difference, range of 95% limits of agreement) obtained were: RV-EDVI, −11.1% (8.7% to −30.8%); RV-ESVI, −3.4% (30.6% to −37.4%); LV-EDVI, −6.0% (9.2% to −21.3%); LV-ESVI, 7.9% (46.8% to −45.2%). Intraclass correlations between cardiac CT and MRI measurements indicated that both radiologic modalities showed excellent consistency in measuring the ventricular volume indices, except for RV-EDVI and LV-ESVI (RV-EDVI, 0.678; RV-ESVI, 0.804; LV-EDVI, 0.836; LV-ESVI, 0.712).
Fig. 2

Bland-Altman plots of the differences between (A) RV-EDVI, (B) RV-ESVI, (C) LV-EDVI, (D) LV-ESVI, (E) RVEF, and (F) LVEF measurements by cardiac MRI and CT. MRI, magnetic resonance imaging; CT, computed tomography; SD, standard deviation; RV, right ventricle; EDVI, end-diastolic volume index; ESVI, end-systolic volume index; LV, left ventricle; EF, ejection fraction.

Discussion

The main findings of this study are as follows: (1) the cardiac CT measurements of RV-EDVI and LV-EDVI were significantly greater than the corresponding MRI measurements, (2) there were no significant differences between cardiac MRI and CT measurements for other volumetric values (RV-ESVI and LV-ESVI), and (3) all measures of volumetric indices by cardiac CT and MRI correlated well, except for the LV-EDVI. To date, cardiac MRI has been the gold standard for measuring ventricular volume. However, shortcomings such as long examination times, the need for general anesthesia in small children, and the increasing use of body implants incompatible with high magnetic fields hamper its routine use in the pediatric population [4]. On the other hand, cardiac CT allows for accurate ventricular volumetry with excellent spatial resolution, and is known to correlate well with cardiac MRI measurements in subjects with normal cardiac anatomy [7]. However, information regarding the collinearity of the ventricular volumetry data obtained either by CT or MRI in patients with congenital heart disease is sparse [5,8,9]. For the measurement of ventricular volumetric indices using MRI, radiologists should draw a line delineating the ventricular cavity, usually excluding the area of heavy trabeculation. Thus, ventricular volume between the trabeculation is usually excluded at the time of volume measurement (i.e., underestimation of the real ventricular volume). If the radiologist includes a large portion of the area of trabeculation as the ventricular cavity, MRI volumetry data may be greater than the actual ventricular volume (i.e., overestimation of the real ventricular volume). CT volumetry measures the area with the same CT number (i.e., the CT number of the blood) and incorporates the ventricular volume between the trabeculations. Thus, it is plausible that CT volumetry data are close to the real ventricular volume. One interesting result from our study was the finding that both the RV-EDVI and LV-EDVI were significantly higher when using cardiac CT (where semiautomatic 3D threshold-based contouring was used) than when using MRI (where simplified contouring was used) for this cohort [6], although a good correlation remained between the data derived from these modalities. This may be attributable to the differences in resolution between the 2 techniques. Compared with cardiac CT, the blood-myocardial contrast is not distinct in cardiac MRI, which leads to low spatial resolution. In contrast, the 3D threshold-based, region-growing contouring method used in cardiac CT may allow more accurate delineation of the endocardial border, as structures such as the trabeculae and papillary muscles can be clearly identified and therefore be excluded from ventricular volume measurements. In addition, the absence of a significant difference in the systolic volume indices between the 2 modalities may be explained by the smaller ventricular volume between the trabeculation during the systolic phase. However, the findings of this study are inconsistent with those of previous studies [6,7], which demonstrated that measured ventricular volumes were comparable regardless of radiologic modalities and contouring methods. Thus, further studies need to be performed to address this issue. Although the 95% limits of agreement in Bland-Altman analysis seemed to be better for the left ventricular volume indices, the ratio of the 95% limits of agreement to the mean measurements by cardiac MRI and cardiac CT was found to be higher for the left ventricular volume indices. This result signifies that smaller discrepancies in the actual numeric values for left-heart dimensions between these radiologic modalities should be interpreted in consideration of the normal reference values. Although this study provides several significant insights, it also has limitations, including a small sample size and the possibility that the smaller ventricular EDVIs found using MRI may have been attributable to an institutional bias towards underestimation of the ventricular volumes, rather than to the inherent characteristics of MRI volumetry. In conclusion, in patients with surgically corrected TOF, ventricular volumetry with cardiac CT using a semiautomatic 3D region-growing method resulted in higher measurements of LV-EDVI and RV-EDVI than volumetry with cardiac MRI using a simplified contouring method. The interpretation of ventricular volumetry results obtained from cardiac CT should therefore be made with caution when making clinical decisions and formulating treatment strategies for this subset of patients.
  9 in total

Review 1.  Accuracy of multi-slice computed tomography for measurement of left ventricular ejection fraction compared with cardiac magnetic resonance imaging and two-dimensional transthoracic echocardiography: a systematic review and meta-analysis.

Authors:  Camilla Asferg; Lotte Usinger; Thomas S Kristensen; Jawdat Abdulla
Journal:  Eur J Radiol       Date:  2012-02-29       Impact factor: 3.528

2.  Evaluation of global and regional left ventricular function with 16-slice computed tomography, biplane cineventriculography, and two-dimensional transthoracic echocardiography: comparison with magnetic resonance imaging.

Authors:  Marc Dewey; Mira Müller; Stephan Eddicks; Dirk Schnapauff; Florian Teige; Wolfgang Rutsch; Adrian C Borges; Bernd Hamm
Journal:  J Am Coll Cardiol       Date:  2006-11-01       Impact factor: 24.094

3.  Multi-detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance.

Authors:  Subha V Raman; Mona Shah; Beth McCarthy; Anne Garcia; Amy K Ferketich
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

Review 4.  MR and CT imaging of the pediatric patient with structural heart disease.

Authors:  Frandics P Chan
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2009

5.  Borderline hypoplasia of the left ventricle in neonates: insights for decision-making from functional assessment with magnetic resonance imaging.

Authors:  Lars Grosse-Wortmann; Tae-Jin Yun; Osman Al-Radi; Siho Kim; Masaki Nii; Kyong-Jin Lee; Andrew Redington; Shi-Joon Yoo; Glen van Arsdell
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09-06       Impact factor: 5.209

6.  Left ventricle volume measured by cardiac CT in an infant with a small left ventricle: a new and accurate method in determining uni- or biventricular repair.

Authors:  Ho Jin Kim; Hyun Woo Goo; Sang-Hyub Park; Tae-Jin Yun
Journal:  Pediatr Radiol       Date:  2012-08-09

7.  Quantification of left ventricular indices from SSFP cine imaging: impact of real-world variability in analysis methodology and utility of geometric modeling.

Authors:  Christopher A Miller; Peter Jordan; Alex Borg; Rachel Argyle; David Clark; Keith Pearce; Matthias Schmitt
Journal:  J Magn Reson Imaging       Date:  2012-11-02       Impact factor: 4.813

8.  Assessment of right ventricular function by 16-detector-row CT: comparison with magnetic resonance imaging.

Authors:  K Koch; F Oellig; K Oberholzer; P Bender; P Kunz; P Mildenberger; U Hake; K-F Kreitner; M Thelen
Journal:  Eur Radiol       Date:  2004-11-24       Impact factor: 5.315

Review 9.  State-of-the-art CT imaging techniques for congenital heart disease.

Authors:  Hyun Woo Goo
Journal:  Korean J Radiol       Date:  2009-12-28       Impact factor: 3.500

  9 in total
  1 in total

Review 1.  Cardiovascular imaging approach in pre and postoperative tetralogy of Fallot.

Authors:  Sotiria C Apostolopoulou; Athanassios Manginas; Nikolaos L Kelekis; Michel Noutsias
Journal:  BMC Cardiovasc Disord       Date:  2019-01-07       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.